Wells Fargo Maintains Overweight on Medtronic, Raises Price Target to $104
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $102 to $104.
Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $102 to $104.